tiprankstipranks
Trending News
More News >
Bright Minds Biosciences (DRUG)
NASDAQ:DRUG
US Market

Bright Minds Biosciences (DRUG) Technical Analysis

Compare
278 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
3Neutral
12Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Bright Minds Biosciences’s (DRUG) Moving Averages Convergence Divergence (MACD) indicator is -2.42, suggesting Bright Minds Biosciences is a Buy.
Bright Minds Biosciences’s (DRUG) 20-Day exponential moving average is 78.06, while Bright Minds Biosciences’s (DRUG) share price is $72.13, making it a Sell.
Bright Minds Biosciences’s (DRUG) 50-Day exponential moving average is 79.07, while Bright Minds Biosciences’s (DRUG) share price is $72.13, making it a Sell.

Bright Minds Biosciences (DRUG) Pivot Points

Mar 19, 2026, 06:54 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
68.00
70.47
71.84
74.30
75.67
78.14
79.51
Fibonacci
70.47
71.93
72.84
74.30
75.77
76.67
78.14
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Bright Minds Biosciences (DRUG) Moving Averages

Mar 19, 2026, 06:54 AM
Period
Simple
Exponential
MA5
73.08Sell
73.60Sell
MA10
75.95Sell
75.71Sell
MA20
80.45Sell
78.06Sell
MA50
82.18Sell
79.07Sell
MA100
75.54Sell
74.08Sell
MA200
57.63Buy
59.59Buy
Bright Minds Biosciences’s (DRUG) 10-Day exponential moving average is 75.71, while Bright Minds Biosciences’s (DRUG) share price is $72.13, making it a Sell.
Bright Minds Biosciences’s (DRUG) 100-Day exponential moving average is 74.08, while Bright Minds Biosciences’s (DRUG) share price is $72.13, making it a Sell.
Bright Minds Biosciences’s (DRUG) stock price is $72.13 and Bright Minds Biosciences’s (DRUG) 50-day simple moving average is 82.18, creating a Sell signal.
Bright Minds Biosciences’s (DRUG) stock price is $72.13 and Bright Minds Biosciences’s (DRUG) 100-day simple moving average is 75.54, creating a Sell signal.
Bright Minds Biosciences’s (DRUG) stock price is $72.13 and Bright Minds Biosciences’s (DRUG) 200-day simple moving average is 57.63, creating a Buy signal.

Bright Minds Biosciences (DRUG) Technical Indicators

Mar 19, 2026, 06:54 AM
Name
Value
Implied Action
RSI (14)
37.86
Neutral
STOCH (9,6)
22.49
Neutral
STOCHRSI (14)
15.64
Buy
MACD (12,26)
-2.42
Buy
ADX (14)
17.88
Buy
Williams %R
-85.78
Buy
CCI (14)
-111.78
Buy
ATR (14)
5.34
-
Ultimate Oscillator
39.52
Neutral
ROC
-19.86
Sell
Bright Minds Biosciences’s (DRUG) Relative Strength Index (RSI) is 37.86, creating a Neutral signal.
Bright Minds Biosciences’s (DRUG) Trend Strength Indicator (ADX) is 17.88, creating a Buy signal.
Bright Minds Biosciences’s (DRUG) Commodity Channel Index (CCI) is -111.78, creating a Buy signal.
Bright Minds Biosciences’s (DRUG) Price Rate of Change (ROC) is -19.86, creating a Sell signal.

FAQ

Is DRUG a Buy, Hold, or Sell?
Based on DRUG’s technical indicators, DRUG is a Sell.
    What is DRUG’s RSI (14)?
    DRUG’s RSI (14) is 37.86, which suggests DRUG is a Neutral.
      What is DRUG’s MACD?
      DRUG’s MACD is -2.42, which suggests DRUG is a Buy.
        What is DRUG’s 5-day moving average?
        DRUG’s 5-day moving average is 73.08, which suggests DRUG is a Sell.
          What is DRUG’s 20-day moving average?
          DRUG 20-day moving average is 80.45, which suggests DRUG is a Sell.
            What is DRUG’s 50-day moving average?
            DRUG’s 50-day moving average is 82.18, which suggests DRUG is a Sell.
              What is DRUG’s 200-day moving average?
              DRUG’s 200-day moving average is 57.63, which suggests DRUG is a Buy.
                What is DRUG’s Williams % R (14)?
                DRUG’s Williams % R (14) is -85.78, which suggests DRUG is a Buy.
                  What is DRUG’s CCI (14)?
                  DRUG’s CCI (14) is -111.78, which suggests DRUG is a Buy.